mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.007 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.007 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.008 |
mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.008 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.008 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.008 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.009 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.009 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.009 |